Article info
PDFOriginal article
Clinicopathological significance of Y416Src and Y527Src expression in breast cancer
- Correspondence to Dr Naoki Kanomata, Department of Pathology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan; kanomata_7{at}med.kawasaki-m.ac.jp
Citation
Clinicopathological significance of Y416Src and Y527Src expression in breast cancer
Publication history
- Accepted March 22, 2011
- First published April 13, 2011.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.